Clinical Study

Association and Predictive Value Analysis for Resting Heart Rate and Diabetes Mellitus on Cardiovascular Autonomic Neuropathy in General Population

Table 2

Univariate logistic regression analysis for cardiovascular autonomic neuropathy.

Variable SE valueOR95% CI

Age0.0420.007<0.0011.041.029–1.103
Gender 0.1760.1170.1341.190.947–1.547
BMI0.0660.016<0.0011.071.034–1.046
WC0.0340.006<0.0011.031.023–1.024
SBP0.0180.003<0.0011.021.012–1.030
DBP0.0190.0060.0011.021.007–1.261
Smoking0.1330.1550.3901.140.843–2.733
MetS0.6460.114<0.0011.911.527–1.307
HT0.7790.116<0.0012.181.736–3.248
HR0.9520.068<0.0012.592.267–2.565
DM0.9360.123<0.0012.552.003–3.156
DM-HR0.4870.033<0.0011.631.525–1.737
FPG0.1780.027<0.0011.191.133–1.149
PBG0.1110.014<0.0011.121.087–1.722
HbAlc0.3920.077<0.0011.481.271–1.026
FINS0.0140.0060.0151.011.003–1.159
IR 0.0910.0290.0011.101.036–1.212
TC0.0820.0560.1421.090.973–1.369
TG0.2130.051<0.0011.241.119–1.129
HDL−0.2250.1770.2030.800.564–1.259
LDL0.0880.0730.2291.090.946–1.005
UA0.0010.0010.2161.000.999–1.108

Note: CAN: cardiovascular autonomic neuropathy; : regression coefficient; SE: standard error; OR: odds ratio; CI: confidence interval; BMI: body mass index; WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; FPG: fasting plasma glucose; PBG: plasma blood glucose; FINS: fasting blood insulin; IR: insulin resistance; TC: serum total cholesterol; TG: triglyceride; UA: uric acid; HDL: high-density lipoprotein cholesterol; LDL: low density lipoprotein cholesterol; SCr: serum creatinine; HR: heart rate; MetS: metabolic syndrome; HT: hypertension; DM: diabetes.